Pacer Advisors Inc. Raises Position in Doximity, Inc. (NASDAQ:DOCS)

Pacer Advisors Inc. lifted its stake in Doximity, Inc. (NASDAQ:DOCS) by 167.6% in the 4th quarter, HoldingsChannel reports. The firm owned 297,132 shares of the company’s stock after acquiring an additional 186,093 shares during the period. Pacer Advisors Inc.’s holdings in Doximity were worth $15,864,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of DOCS. UMB Bank n.a. raised its stake in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after buying an additional 235 shares during the period. Farther Finance Advisors LLC increased its stake in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares in the last quarter. Quarry LP raised its position in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after purchasing an additional 131,253 shares during the period. Morse Asset Management Inc purchased a new position in shares of Doximity during the 3rd quarter valued at $46,000. Finally, GAMMA Investing LLC boosted its holdings in Doximity by 40.1% in the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Doximity Trading Up 3.3 %

NASDAQ:DOCS opened at $57.17 on Wednesday. The company has a market cap of $10.67 billion, a price-to-earnings ratio of 65.71, a price-to-earnings-growth ratio of 4.43 and a beta of 1.38. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The stock has a fifty day simple moving average of $53.98 and a 200-day simple moving average of $44.06.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.02). Doximity had a net margin of 33.69% and a return on equity of 19.79%. The company had revenue of $136.83 million for the quarter, compared to the consensus estimate of $127.05 million. During the same period in the prior year, the firm posted $0.18 EPS. As a group, equities research analysts predict that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Analysts Set New Price Targets

DOCS has been the topic of several research analyst reports. Barclays boosted their price objective on Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a research report on Monday, November 11th. Raymond James reaffirmed an “outperform” rating and set a $65.00 price objective (up from $37.00) on shares of Doximity in a report on Friday, November 8th. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and boosted their target price for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. Wells Fargo & Company raised their target price on shares of Doximity from $41.00 to $43.00 and gave the company an “equal weight” rating in a research note on Monday, January 13th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a research note on Thursday, November 21st. Thirteen research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $53.12.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.